These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 568381)

  • 1. The effect of heparin on the activated partial thromboplastin time.
    Triplett DA; Harms CS; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):556-9. PubMed ID: 568381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII (antihemophilic factor) assay results in the 1976 College of American Pathologists Survey Program.
    Harms CS; Triplett DA; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):560-2. PubMed ID: 707422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.
    Ts'ao CH; Galluzzo TS; Lo R; Peterson KG
    Am J Clin Pathol; 1979 Jan; 71(1):17-21. PubMed ID: 420167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation among commercial activated partial thromboplastin time reagents in response to heparin.
    Shapiro GA; Huntzinger SW; Wilson JE
    Am J Clin Pathol; 1977 May; 67(5):477-80. PubMed ID: 857645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control of heparin therapy by the activated partial thromboplastin time: results of collaborative studies.
    Thomson JM
    Scand J Haematol Suppl; 1980; 37():73-83. PubMed ID: 6941440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory monitoring of heparin therapy--the effect of different salts of heparin on the activated partial thromboplastin time.
    Banez EI; Triplett DA; Koepke J
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):569-74. PubMed ID: 7435450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variations between heparin sensitivity of different lots of activated partial thromboplastin time reagent produced by the same manufacturer.
    Shojania AM; Tetreault J; Turnbull G
    Am J Clin Pathol; 1988 Jan; 89(1):19-23. PubMed ID: 3337049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PiCT
    Brisset AC; Ferrández A; Krause M; Rathbun S; Marlar R; Korte W
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
    Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
    Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of heparin on the activated partial thromboplastin time of the College of American Pathologists Survey specimens. Responsiveness, precision, and sample effects.
    Gawoski JM; Arkin CF; Bovill T; Brandt J; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1987 Sep; 111(9):785-90. PubMed ID: 3632297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT.
    D'Angelo A; Seveso MP; D'Angelo SV; Gilardoni F; Dettori AG; Bonini P
    Am J Clin Pathol; 1990 Sep; 94(3):297-306. PubMed ID: 2396604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preparation of a sensitive partial thromboplastin reagent from bovine brain.
    Martin BA; Branch DW; Rodgers GM
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):287-94. PubMed ID: 1643206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
    Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
    Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma heparin: a simple, one-sample determination of both effect and concentration based on the activated partial thromboplastin time.
    Hoffman JJ; Meulendijk PN
    Clin Chim Acta; 1978 Aug; 87(3):417-24. PubMed ID: 679478
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of calcium ions on the activated partial thromboplastin time of heparinized plasma.
    Greenberg CS; Adams JP; Mullen PE; Koepke JA
    Am J Clin Pathol; 1986 Oct; 86(4):484-9. PubMed ID: 3766461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin in vitro sensitivity of the activated partial thromboplastin time in canine plasma depends on reagent.
    Mischke R
    J Vet Diagn Invest; 2003 Nov; 15(6):588-91. PubMed ID: 14667026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in heparin sensitivity of APTT reagents.
    Bjornsson TD; Nash PV
    Am J Clin Pathol; 1986 Aug; 86(2):199-204. PubMed ID: 3739971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing different lots of activated partial thromboplastin time reagent: analysis of two methods.
    Rosborough TK
    Am J Clin Pathol; 1998 Aug; 110(2):173-7. PubMed ID: 9704615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the activated partial thromboplastin time for monitoring heparin therapy: problems and possible solutions.
    Poller L; Thomson JM; Taberner DA
    Ric Clin Lab; 1989; 19(4):363-70. PubMed ID: 2633304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time.
    Brandt JT; Triplett DA
    Am J Clin Pathol; 1981 Oct; 76(4 Suppl):530-7. PubMed ID: 7282639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.